Previous close | 2.2400 |
Open | 2.2700 |
Bid | 2.0700 x 400 |
Ask | 2.1200 x 400 |
Day's range | 2.0700 - 2.3000 |
52-week range | 1.3000 - 6.3000 |
Volume | |
Avg. volume | 477,920 |
Market cap | 114.171M |
Beta (5Y monthly) | 1.90 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Nurix Therapeutics (NRIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Omega Therapeutics ( NASDAQ:OMGA ) First Quarter 2024 Results Key Financial Results Net loss: US$20.1m (loss narrowed...
Omega Therapeutics (OMGA) delivered earnings and revenue surprises of 5.26% and 155.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?